Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Is This The Next Billion-Dollar Biotech Idea?

12/05/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndivmjavotqvzmlszsjdlfsiccisinrodw1iiiwinjawedqwmfx1mdazzsjdxq

Developing a new drug costs hundreds of millions of dollars, but for every five drugs that reach the market, another 95 end up in the trash bin.

That makes finding the next big thing in biotech particularly hit or miss. Frankly, the odds are stacked against biotech investors, because the odds are stacked against the biotech industry.

Small biotech companies generally have just one or two compelling ideas under development, which means that if one fails, the stock will take a substantial hit. That doesn’t mean, however, that investors can’t benefit from billion-dollar biotech blockbusters; it simply means they may want to develop a better strategy.

Rather than focusing on fly by night, unproven therapies, investors may want to look for opportunities to capture the billions of dollars in sales that are already being generated by the largest drug makers in the world.

That leads me to what I believe may be one of the biggest coming long-term trends in biotech: biosimilars. These are generic, copycat versions of biologic drugs such as AbbV blockbuster autoimmune drug Humira.

This article has been extracted from http://www.fool.com, please click on this link to read the article in full http://www.fool.com/investing/general/2014/05/11/is-this-the-next-billion-dollar-biotech-idea.aspx

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit www.montash.com

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdkvmjevmdgvndmvmduvmtmxl1vudgl0bgvkigrlc2lnbiaomjmplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Why do we punish the victims of hacking?

2017-09-21 09:00:00 +0100

Hacks occur every 39 seconds, with 95% of them targeting governments, retailers and the tech industry. If the hackers are caught, they'll face prison time under the Computer Misuse Act. More often than not, the businesses who are victims of those attacks expose themselves to punishment of their own. The laws that determine the duty of protection owed to businesses and their customers is both vague and broad, making them question just how much protection...

W1siziisijiwmtcvmdkvmtgvmtavmtivndyvodeyl1dvbwvuigluihrly2ggkdiplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Tech is for girls... and always has been!

2017-09-18 10:00:00 +0100

Today, it's hard to deny that the IT and tech industry is a male-dominated field. Women earn only 28%[1] of computer science degrees, while the quit rate for women in the high tech industry is 41%[2], twice as high as it is for men. These two statistics would suggest that perhaps women aren't just discouraged from entering the tech field, but may find it a challenging environment to work in both in terms of treatment and pay. Facebook chief operating of...